Multi-state models provide an extension of the usual survival/event-history analysis setting. In the medical domain, multi-state models give the possibility of further investigating intermediate events such as relapse and remission. In this work, a further extension is proposed using relative survival, where mortality due to population causes (i.e. non-disease-related mortality) is evaluated. The objective is to split all mortality in disease and non-disease-related mortality, with and without intermediate events, in datasets where cause of death is not recorded or is uncertain. To this end, population mortality tables are integrated into the estimation process, while using the basic relative survival idea that the overall mortality hazard can be written as a sum of a population and an excess part. Hence, we propose an upgraded non-parametric approach to estimation, where population mortality is taken into account. Precise definitions and suitable estimators are given for both the transition hazards and probabilities. Variance estimating techniques and confidence intervals are introduced and the behaviour of the new method is investigated through simulations. The newly developed methodology is illustrated by the analysis of a cohort of patients followed after an allogeneic hematopoietic stem cell transplantation. The work is also implemented in the R package mstate.
翻译:在医疗领域,多州模式提供了进一步调查诸如复发和再释等中间事件的可能性;在这项工作中,提议使用相对生存方法进一步扩展,对人口原因(即与疾病无关的死亡率)造成的死亡进行评估;目标是在没有记录或不确定死亡原因的数据集中,将疾病和非疾病相关死亡率的所有死亡率,以及不记录或不发生中间事件的所有死亡率分开;为此,将人口死亡率表纳入估计过程,同时使用基本相对生存概念,即总体死亡率危险可以作为人口的总和和和和过剩部分来写;因此,我们提议在考虑人口死亡率的情况下,对估计采用非参数性方法进行升级;对过渡性危害和概率作出精确的定义和适当的估计;采用差异估计技术和信任度,并通过模拟调查新方法的行为;新开发的细胞通过对已实施的所有基因移植后病人组的分析加以说明。